We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
-0.86%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$1.19B
AUM Growth
-$288M
Cap. Flow
-$155M
Cap. Flow %
-13.04%
Top 10 Hldgs %
42.35%
Holding
170
New
36
Increased
27
Reduced
26
Closed
54

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$49M
2
LLY icon
Eli Lilly
LLY
+$41.1M
3
ABBV icon
AbbVie
ABBV
+$26.3M
4
PANW icon
Palo Alto Networks
PANW
+$13.1M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$11.8M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$60.1M
2
JNJ icon
Johnson & Johnson
JNJ
+$28.4M
3
GNRC icon
Generac Holdings
GNRC
+$14.3M
4
LPSN icon
LivePerson
LPSN
+$14.2M
5
AMZN icon
Amazon
AMZN
+$13.5M

Sector Composition

Rank Sector Weight
1 Healthcare 63.14%
2 Technology 10.82%
3 Industrials 3.99%
4 Financials 3.13%
5 Communication Services 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FVRR icon
126
CALL
Fiverr
FVRR
$321M
– –
-79,000
Closed -$19.2M
FVRR icon
127
Fiverr
FVRR
$321M
– –
-21,500
Closed -$5.21M
GBTG icon
128
American Express Global Business Travel
GBTG
$4.93B
– –
-73,055
Closed -$714K
IGV icon
129
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$12.7B
– –
-525,000
Closed -$41M
NBP
130
NovaBridge Biosciences American Depositary Shares
NBP
$185M
– –
-46,350
Closed -$3.89M
IPSC icon
131
Century Therapeutics
IPSC
$364M
– –
-80,000
Closed -$2.35M
KRRO icon
132
Korro Bio
KRRO
$150M
– –
-5,503
Closed -$2.74M
LPSN icon
133
LivePerson
LPSN
$21.8M
– –
-15,000
Closed -$14.2M
MRK icon
134
Merck
MRK
$322B
– –
-772,601
Closed -$60.1M
MRK icon
135
PUT
Merck
MRK
$322B
– –
-772,600
Closed -$60.1M
NEXN
136
Nexxen International
NEXN
$573M
– –
-150,000
Closed -$2.98M
NKTX icon
137
Nkarta
NKTX
$150M
– –
-252,478
Closed -$8M
NRIX icon
138
Nurix Therapeutics
NRIX
$2.41B
– –
-244,157
Closed -$6.48M
ONTO icon
139
Onto Innovation
ONTO
$12.9B
– –
-107,548
Closed -$7.86M
PLRX icon
140
Pliant Therapeutics
PLRX
$64.4M
– –
-51,000
Closed -$1.49M
PLTK icon
141
Playtika
PLTK
$1.52B
– –
-150,000
Closed -$3.58M
PRAX icon
142
Praxis Precision Medicines
PRAX
$8.58B
– –
-5,040
Closed -$1.38M
PRGO icon
143
Perrigo
PRGO
$1.4B
– –
-52,500
Closed -$2.41M
S icon
144
SentinelOne
S
$6.53B
– –
-68,400
Closed -$2.91M
SPRY icon
145
ARS Pharmaceuticals
SPRY
$509M
– –
-173,891
Closed -$5.37M
STOK icon
146
Stoke Therapeutics
STOK
$1.8B
– –
-233,135
Closed -$7.85M
STTK icon
147
Shattuck Labs
STTK
$675M
– –
-274,214
Closed -$7.95M
TAN icon
148
CALL
Invesco Solar ETF
TAN
$1.42B
– –
-210,000
Closed -$18.8M
TOI icon
149
The Oncology Institute
TOI
$486M
– –
-126,491
Closed -$1.26M
TWST icon
150
Twist Bioscience
TWST
$5.7B
– –
-18,000
Closed -$2.4M
3 4 5
6
7

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2021 Portfolio in Review

As of Q3 2021, Sphera Funds Management held 170 positions worth $1.19B, down 19% from $1.48B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sphera Funds Management withdrew a net $155M in Q3 2021, closing 54 positions and reducing 26 holdings. Its most notable exit was Merck, an estimated $60.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 55% a quarter earlier, followed by Technology and Industrials.

Against the trend, Sphera Funds Management opened a new position in Pfizer worth $47.6M.

  • Sphera Funds Management's largest Q3 2021 buy was Pfizer: 1,106,528 shares worth $47.6M.
  • Sphera Funds Management added most to Eli Lilly in Q3 2021, an estimated $41.1M increase.
  • Sphera Funds Management's biggest Q3 2021 reduction was Johnson & Johnson, cutting an estimated $28.4M.
  • Sphera Funds Management fully exited Merck in Q3 2021, selling an estimated $60.1M.
  • Sphera Funds Management's ten largest holdings make up 42% of its $1.19B portfolio in Q3 2021.
  • Sphera Funds Management opened 36 new positions and closed 54 in Q3 2021.
  • Sphera Funds Management's portfolio value fell 19% quarter-over-quarter to $1.19B.

Based on Sphera Funds Management's 13F filing for Q3 2021, filed 15 Nov 2021.